In the News

9 News Australia discusses VECTRA® WB360’s Revolutionary Melanoma Screening Technology with Prof. Pablo Fernandez-Penas

9 News Australia discusses Canfield’s revolutionary VECTRA WB360 technology with DermaGraphix® software and its role in skin screening at Westmead Hospital. DermaGraphix® enhances screenings, assists with early diagnoses, and provides long-term skin surveillance of the whole body in a singular 3D avatar of the patient. Patient, Gayle Johnston, had her entire body scanned effectively and efficiently in the whole-body imaging system, leading to the discovery of a suspicious mole on her forearm.

Happy Holidays from Canfield and YCS!

From all of us here at Canfield Scientific, we wish you a healthy Holiday season and a Happy New Year! For over twenty years, Canfield Scientific has been sponsoring a Holiday Gift Donation for the children of Youth Consultation Service (YCS). With locations throughout New Jersey, YCS focuses on helping families stay together during a crisis with intervention and counseling. The illustrations you see here are the work of these children and we are honored to be able to support them this Holiday season.

Canfield Scientific announces ISO 27001 Certification for the Information Security Management System for Clinical Trials

Canfield Scientific, the global leader providing skin imaging systems and services for pharmaceutical, biotech, and medical device companies, is pleased to announce it has achieved ISO/IEC 27001:2013 (ISO 27001) certification. Having ISO 27001 certification signifies Canfield’s commitment to the security, confidentiality, integrity, and availability of sensitive health-related patient and customer information.

Canfield Scientific s.r.l to host Dreamoscopy™ 2 – Imaging in the Modern Dermatology Clinic

Following last year’s successful launch of the world-class medical dermatology education program Dreamoscopy™, Alfredo Medici and the Canfield s.r.l. team will be conducting Dreamoscopy 2: Imaging in the Modern Dermatology Clinic. The event will be taking place on December 3rd, 2022, at their state-of-the-art facility in Spilamberto (Modena), Italy.

The first VECTRA® WB360 whole-body imaging system in Greece, donated by Onassis Foundation, has just been installed in “Andreas Syggros” Hospital Melanoma and Skin Cancer Center

Canfield’s VECTRA WB360 whole-body imaging system was recently donated to the “Andreas Syggros” Hospital by the Onassis Foundation, marking the first WB360 system to be featured in a Greek hospital. This system, which can offer 3D imaging through 46 stereo-vision pods that take pictures with cross-polarized and non-polarized lighting, generating a single 3D image of the entire body, is considered the future of Dermatology and Skin Oncology. As an addition to the newly reconstructed Melanoma and Skin Cancer Center, the 3D imaging system will provide clinicians and researchers the ability to identify changes in suspicious lesions on the surface of the skin over time. The WB360 creates a precise 3D body map of the patient, which gives “Andreas Syggros” Hospital a way to combat the country’s high rate of melanoma. As of today, VECTRA WB360, a synonym for medical innovation and research in the field of dermatology, will safeguard the extraordinary work undertaken in this updated Center.

VECTRA® H2 Featured in Face and Body Germany Magazine

In the September 2022 issue of Face and Body Germany, Prof. Dr. med. Dimitra Kotsougiani-Fischer of AESTHETIKON in Mannheim and Heidelberg Germany discusses how the VECTRA H2 enables detailed preoperative documentation and quantifies volume defects quickly and easily.

Canfield Sponsors the Mission to Raise $250,000 for Melanoma Research

Last week, ten doctors broke the Guinness World Record for the fastest time to row one million meters and raised around $245,000 for melanoma and skin cancer research at the University of Queensland Dermatology Research Centre. The endurance rowing challenge to break the record for the fastest team to row one million meters was in honor of team leader, Dr Chris Conyard’s sister-in-law, Phoebe Eales, who passed away at 31 as a result of melanoma.

FaceReality Awarded 3rd place in IMCAS 2022 Innovation of the Year Competition

In June, FaceReality, an AI driven module within Canfield’s Mirror® for iPad® app, was awarded 3rd place in the IMCAS Innovation of the Year competition series. The series highlights the latest advances in the fields of dermatology, plastic surgery, skincare, and aesthetic science.

ABC-7 TV in New York City Features VECTRA® WB360 in Melanoma May Segment

This story features Scott Rosato, a melanoma patient of Memorial Sloan Kettering Cancer Center and his journey to monitor the 700 moles on his body. Scott and his doctors have been observing his skin carefully for 25 years, since the first of 20 melanomas was removed. Under the care of Dr. Ashfaq Marghoob, a renowned skin cancer expert, Rosato now gets his entire body scanned quickly and efficiently in Canfield’s VECTRA WB360 whole-body imaging system. The system captures patient images using 46 stereo vision pods and captures cross polarized and non-polarized images to create a precise 3D body map of the patient. The 3D body map is designed to assist clinicians and researchers with identifying changes in suspicious lesions on the surface of the skin over time and will help Dr. Marghoob with lesions requiring closer examination.

VECTRA® WB360 whole-body imaging system installed in Hopital de la Conception-AP-HM Marseille, the first installation in France

Canfield’s VECTRA WB360 was recently installed at the Hopital de la Conception-AP-HM Marseille, making it the first WB360 system to be featured in a French hospital. The whole-body imaging system will be the centerpiece of the hospital’s multi-room system for clinical dermatology, where it includes rooms for body mapping and confocal microscopy. The VECTRA WB360 captures patient images using 46 stereo vision pods with cross-polarized and non-polarized lighting, generating a single 3D image of the entire body. Incorporating Canfield’s AI-driven DermaGraphix® software, the 3D images are used for pigmented lesion and rash surveillance. Using VECTRA’S 3D imaging technology Prof. Jean-Jacques Grob and Jilliana Monnier, MD can examine individual lesions, record data, and monitor patients over time. This latest installation in Marseille is one of fifteen WB360 systems in Europe and is the fifth system so far in 2022.